AU1372097A - Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for the production of a medicament for respiratory stimulation - Google Patents

Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for the production of a medicament for respiratory stimulation

Info

Publication number
AU1372097A
AU1372097A AU13720/97A AU1372097A AU1372097A AU 1372097 A AU1372097 A AU 1372097A AU 13720/97 A AU13720/97 A AU 13720/97A AU 1372097 A AU1372097 A AU 1372097A AU 1372097 A AU1372097 A AU 1372097A
Authority
AU
Australia
Prior art keywords
nhe
medicament
inhibitors
exchanger
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU13720/97A
Other versions
AU717247B2 (en
Inventor
Joachim Brendel
Hans-Willi Jansen
Heinz-Werner Kleemann
Hans Jochen Lang
Wolfgang Scholz
Jan-Robert Schwark
Andreas Weichert
Klaus Wirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU1372097A publication Critical patent/AU1372097A/en
Application granted granted Critical
Publication of AU717247B2 publication Critical patent/AU717247B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60L—PROPULSION OF ELECTRICALLY-PROPELLED VEHICLES; SUPPLYING ELECTRIC POWER FOR AUXILIARY EQUIPMENT OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRODYNAMIC BRAKE SYSTEMS FOR VEHICLES IN GENERAL; MAGNETIC SUSPENSION OR LEVITATION FOR VEHICLES; MONITORING OPERATING VARIABLES OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRIC SAFETY DEVICES FOR ELECTRICALLY-PROPELLED VEHICLES
    • B60L50/00—Electric propulsion with power supplied within the vehicle
    • B60L50/50—Electric propulsion with power supplied within the vehicle using propulsion power supplied by batteries or fuel cells
    • B60L50/60—Electric propulsion with power supplied within the vehicle using propulsion power supplied by batteries or fuel cells using power supplied by batteries
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60L—PROPULSION OF ELECTRICALLY-PROPELLED VEHICLES; SUPPLYING ELECTRIC POWER FOR AUXILIARY EQUIPMENT OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRODYNAMIC BRAKE SYSTEMS FOR VEHICLES IN GENERAL; MAGNETIC SUSPENSION OR LEVITATION FOR VEHICLES; MONITORING OPERATING VARIABLES OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRIC SAFETY DEVICES FOR ELECTRICALLY-PROPELLED VEHICLES
    • B60L7/00—Electrodynamic brake systems for vehicles in general
    • B60L7/10—Dynamic electric regenerative braking
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60L—PROPULSION OF ELECTRICALLY-PROPELLED VEHICLES; SUPPLYING ELECTRIC POWER FOR AUXILIARY EQUIPMENT OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRODYNAMIC BRAKE SYSTEMS FOR VEHICLES IN GENERAL; MAGNETIC SUSPENSION OR LEVITATION FOR VEHICLES; MONITORING OPERATING VARIABLES OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRIC SAFETY DEVICES FOR ELECTRICALLY-PROPELLED VEHICLES
    • B60L7/00—Electrodynamic brake systems for vehicles in general
    • B60L7/10—Dynamic electric regenerative braking
    • B60L7/16—Dynamic electric regenerative braking for vehicles comprising converters between the power source and the motor
    • E—FIXED CONSTRUCTIONS
    • E01—CONSTRUCTION OF ROADS, RAILWAYS, OR BRIDGES
    • E01C—CONSTRUCTION OF, OR SURFACES FOR, ROADS, SPORTS GROUNDS, OR THE LIKE; MACHINES OR AUXILIARY TOOLS FOR CONSTRUCTION OR REPAIR
    • E01C19/00—Machines, tools or auxiliary devices for preparing or distributing paving materials, for working the placed materials, or for forming, consolidating, or finishing the paving
    • E01C19/22—Machines, tools or auxiliary devices for preparing or distributing paving materials, for working the placed materials, or for forming, consolidating, or finishing the paving for consolidating or finishing laid-down unset materials
    • E01C19/23—Rollers therefor; Such rollers usable also for compacting soil
    • E01C19/26—Rollers therefor; Such rollers usable also for compacting soil self-propelled or fitted to road vehicles
    • E—FIXED CONSTRUCTIONS
    • E01—CONSTRUCTION OF ROADS, RAILWAYS, OR BRIDGES
    • E01C—CONSTRUCTION OF, OR SURFACES FOR, ROADS, SPORTS GROUNDS, OR THE LIKE; MACHINES OR AUXILIARY TOOLS FOR CONSTRUCTION OR REPAIR
    • E01C19/00—Machines, tools or auxiliary devices for preparing or distributing paving materials, for working the placed materials, or for forming, consolidating, or finishing the paving
    • E01C19/22—Machines, tools or auxiliary devices for preparing or distributing paving materials, for working the placed materials, or for forming, consolidating, or finishing the paving for consolidating or finishing laid-down unset materials
    • E01C19/23—Rollers therefor; Such rollers usable also for compacting soil
    • E01C19/28—Vibrated rollers or rollers subjected to impacts, e.g. hammering blows
AU13720/97A 1995-12-27 1996-12-13 Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for the production of a medicament for respiratory stimulation Ceased AU717247B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19548812A DE19548812A1 (en) 1995-12-27 1995-12-27 Use of inhibitors of the cellular Na · + · / H · + · exchanger (NHE) for the manufacture of a medicament for respiratory stimulation
DE19548812 1995-12-27
PCT/EP1996/005614 WO1997024113A1 (en) 1995-12-27 1996-12-13 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR THE PREPARATION OF A DRUG FOR RESPIRATORY STIMULATION

Publications (2)

Publication Number Publication Date
AU1372097A true AU1372097A (en) 1997-07-28
AU717247B2 AU717247B2 (en) 2000-03-23

Family

ID=7781474

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13720/97A Ceased AU717247B2 (en) 1995-12-27 1996-12-13 Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for the production of a medicament for respiratory stimulation

Country Status (16)

Country Link
EP (1) EP0869779A1 (en)
KR (1) KR19990076802A (en)
CN (1) CN1207676A (en)
AU (1) AU717247B2 (en)
BR (1) BR9612287A (en)
CA (1) CA2241531A1 (en)
CZ (1) CZ202198DA3 (en)
DE (1) DE19548812A1 (en)
HU (1) HUP9900807A3 (en)
IL (1) IL125114A0 (en)
MX (1) MX9805141A (en)
NO (1) NO982989L (en)
PL (1) PL327693A1 (en)
SK (1) SK88398A3 (en)
TR (1) TR199801235T2 (en)
WO (1) WO1997024113A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9504537D0 (en) * 1995-12-19 1995-12-19 Jan Hedner Ways of treating and diagnosing respiratory disorders during sleep and means of performing the method
DE19945302A1 (en) * 1999-09-22 2001-03-29 Merck Patent Gmbh Biphenyl derivatives as NHE-3 inhibitors
DE10060292A1 (en) * 2000-12-05 2002-06-20 Aventis Pharma Gmbh Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibition of the Na + / H + exchanger and medicament containing them
DE10163239A1 (en) * 2001-12-21 2003-07-10 Aventis Pharma Gmbh Substituted imidazolidines, process for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
PL2384318T3 (en) 2008-12-31 2018-04-30 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP2887964B1 (en) 2012-08-21 2019-07-03 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
RS58969B1 (en) 2013-04-12 2019-08-30 Ardelyx Inc Nhe3-binding compounds and methods for inhibiting phosphate transport
MY182318A (en) 2014-07-25 2021-01-19 Taisho Pharmaceutical Co Ltd Phenyl tetrahydroisoquinoline compound substituted with heteroaryl
WO2018129557A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Inhibitors of nhe-mediated antiport
JP7292207B2 (en) 2017-01-09 2023-06-16 アルデリックス， インコーポレイテッド Compounds Useful for Treating Gastrointestinal Disorders
BR112020002322A2 (en) 2017-08-04 2020-09-01 Ardelyx, Inc. glycyrrhetinic acid derivatives for the treatment of hyperkalaemia
EP4234016A3 (en) 2019-02-07 2023-10-18 Ardelyx, Inc. Glycyrrhetinic acid derivatives for use in treating hyperkalemia
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4325822A1 (en) * 1993-07-31 1995-02-02 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
EP0639573A1 (en) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it
DE4337609A1 (en) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Novel pyrazinecarboxamide derivatives, their preparation and their use in medicines
DE4415873A1 (en) * 1994-05-05 1995-11-09 Hoechst Ag Substituted bicyclic heteroaroylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them

Also Published As

Publication number Publication date
NO982989D0 (en) 1998-06-26
CN1207676A (en) 1999-02-10
DE19548812A1 (en) 1997-07-03
TR199801235T2 (en) 1998-10-21
HUP9900807A2 (en) 1999-07-28
BR9612287A (en) 2005-05-24
SK88398A3 (en) 1999-03-12
MX9805141A (en) 1998-10-31
WO1997024113A1 (en) 1997-07-10
CA2241531A1 (en) 1997-07-10
IL125114A0 (en) 1999-01-26
NO982989L (en) 1998-08-06
CZ202198DA3 (en) 1998-11-11
AU717247B2 (en) 2000-03-23
KR19990076802A (en) 1999-10-15
PL327693A1 (en) 1998-12-21
EP0869779A1 (en) 1998-10-14
HUP9900807A3 (en) 2000-11-28

Similar Documents

Publication Publication Date Title
CZ202198DA3 (en) USE OF Na+/H+ EXCHANGE INHIBITORS FOR PREPARING A MEDICAMENT INTENDED FOR TREATING IMPAIRED STIMULATION OF BREATHING
AU2957697A (en) Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for the production of a medicament for the normalization of serum lipids
HUP9801777A3 (en) Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
AU4050195A (en) Soft gelatin pharmaceutical dosage form
HUP9801877A3 (en) Medicaments containing tetrahydrofuryl-sulphonamide-derivative as inhibitors of aspartyl-proteases
AU5016593A (en) Apparatus for the diagnosis of sleep apnea
EP0711559A3 (en) Use of phosphatidylserines for the manufacture of a medicament for improving cerebration
ZA957187B (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments
CA2182939A1 (en) A rapidly disintegrating medicinal form of tramadol or a tramadol salt
AU3949889A (en) The reductive amination of hydroxy-containing compounds
AU4477893A (en) Use of C1-inactivator for the production of a pharmaceutical for the prophylaxis and therapy of certain diseases
HU9502426D0 (en) Compounds of pharmaceutical activity
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
HUP9802731A3 (en) Vitamin d analogues, use thereof, medicaments containing them, their production
AU3574793A (en) Remedy for airway diseases
AU4081393A (en) Medicaments for the treatment of anxiety
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
IL126068A0 (en) The use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substances on the heart
HUP9801846A3 (en) 17-difluoromethylene-oestratrienes, use thereof medicaments containing them and process for production of compounds
GB9503230D0 (en) Manufacture of printing plates by photo-ablation
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
HUP9900916A3 (en) Use of benzotiophene derivatives for the production of medicaments having calcium channel antagonistic activity
AU7383994A (en) Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases
EP0514124A3 (en) Use of phosphonomethylphosphinate squalene synthetase inhibitors for the manufacture of a medicament for the lowering cholesterol

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired